Risks of high-grade arterial hypertension and high-grade reduction in left ventricular ejection fraction (LVEF) are increased for patients with advanced melanoma treated with a combination of BRAF and MEK inhibitors compared with those treated with BRAF inhibitor alone, according to study results published in JAMA Open Network.
Archive | Clinical Trials
TKI Combination vs Monotherapy for Advanced Melanoma and the Risk for CV Adverse Events
Posted in Melanoma News, Health Professionals, Clinical Trials
Upcoming events – Roche and Novartis hope to push forward again in melanoma
Welcome to your weekly roundup of approaching clinical readouts.
Posted in Melanoma News, Health Professionals, Clinical Trials
Skin patch could painlessly deliver vaccines, cancer medications in one minute
SAN DIEGO, Aug. 25, 2019 — Melanoma is a deadly form of skin cancer that has been increasing in the U.S. for the past 30 years. Nearly 100,000 new cases of melanoma are diagnosed every year, and 20 Americans die every day from it, according to the American Academy of Dermatology
Posted in Melanoma News, Health Professionals, Clinical Trials
CheckMate 204 Update: Practice-Changing for Brain Metastases?
I am Jeffrey Weber, a medical oncologist at the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health in New York City.
Posted in Melanoma News, Health Professionals, Clinical Trials
